Noliprel A, 2.5 mg+0.625 mg, film-coated tablets, 90 pcs.

Compound

The drug Noliprel is offered in several different forms. All variations of the drug include perindopril and indapamide . Combined Noliprel contain 2 mg of perindopril and 0.625 mg of indapamide. The composition of Noliprel Forte includes 4 mg of perindopril and 1.25 mg of indapamide. Noliprel A contains 2.5 mg of perindopril and 0.625 mg of indapamide.
In this drug, perindopril is associated with the amino acid arginine, which has a beneficial effect on the condition of the cardiovascular system. Noliprel A Forte tablets contain 5 mg of perindopril and 1.25 mg of indapamide. Noliprel A Bi-forte contains 10 mg of perindopril and 2.5 mg of indapamide.

As additional substances in the composition of the drug Noliprel there is magnesium stearate, lactose monohydrate, colloidal hydrophobic silicon dioxide, microcrystalline cellulose.

Description of the original drug

Composition and release form

The drug Noliprel is produced in tablet form. Biconvex tablets of round shape and white color are packaged in individual blister cells. Each blister contains 14 tablets. Instructions for use are included. The price of Noliprel starts from 540 rubles.

The drug contains two main active ingredients: perindopril (2 mg), indapamide (625 mcg).

Other components of the drug for blood pressure:

• microcrystalline cellulose;
• lactose monohydrate;
• magnesium stearate;
• polysorb.

Pharmacological properties

The action of the blood pressure drug Noliprel is aimed at inhibiting the angiotensin-converting enzyme. The drug prevents angiotensin-1 from being converted into angiotensin-2, which is responsible for vasoconstriction. Under the influence of the tablets, the blood vessels dilate, excess water and sodium are removed from the body. ACEIs normalize the condition of patients with chronic heart failure.

The blood pressure medication is well absorbed after administration. The maximum content is reached 4 hours after administration. Metabolites of the drug are excreted through the kidneys within 24 hours.

Noliprel tablets

Reception scheme

The tablets are taken orally whole with a sufficient amount of water. The drug has a pronounced prolonged effect, so 1 tablet is prescribed per day. It is recommended to take the tablet in the morning before meals. In case of renal failure, no dosage adjustment is required.

Contraindications

Noliprel blood pressure tablets are contraindicated when:

• pregnancy;
• impairment of all kidney functions;
• increased susceptibility to ACE inhibitor components;
• individual intolerance to components;
• angioedema;
• hypokalemia;
• liver dysfunction;
• use of cardiac drugs.

It is necessary to take the blood pressure drug Noliprel with caution when:

• heart and vascular diseases;
• hypolactasia;
• renal failure;
• diabetes;
• connective tissue dysplasia;
• violation of metabolic processes;
• gout;
• dehydration due to diuretics.

To avoid unwanted effects from taking Noliprel, you should take the drug strictly as prescribed by your doctor.

Side effects

Taking the blood pressure drug Noliprel can cause adverse reactions in the body:

• indigestion;
• hepatitis;
• nervous system disorders;
• tinnitus;
• disorders of the heart and blood vessels;
• arrhythmia;
• respiratory disorders;
• urinary disturbance;
• itching;
• decreased blood counts.

Overdose

In case of an overdose, the patient experiences vomiting, seizures, and weakness. In case of overdose, it is necessary to rinse the stomach, give an adsorbent and call a doctor.

Drug interactions

Parallel use of other antihypertensive drugs increases the effectiveness of Noliprel tablets.

Nonsteroidal anti-inflammatory drugs reduce the hypotensive effect of Noliprel.

Potassium-containing drugs and diuretics can increase the level of potassium in the blood.

Tablets can be replaced with Bisoprolol.

pharmachologic effect

Noliprel is a combination drug that contains perindopril (an angiotensin-converting factor inhibitor) and indapamide (a diuretic that is part of the sulfonamide group).

The pharmacological effect of a drug is determined by a combination of some of the effects of these components. In this combination, both components mutually increase the effect. Noliprel is an antihypertensive drug that effectively lowers both diastolic and systolic blood pressure. The severity of the effect depends on the dose. After taking the drug, there is no rapid heartbeat. The clinical effect is observed 1 month after treatment was started. The antihypertensive effect lasts for one day. After therapy is suspended, the patient does not experience withdrawal symptoms. During treatment, the severity of left ventricular hypertrophy decreases, and the degree of total precardiac and postcardiac load decreases. Large vessels become more elastic, the walls of small vessels are restored. The medicine has no effect on the metabolic processes that occur in the body.

Perindopril reduces the level of aldosterone secretion, resulting in increased renin activity in the blood. Blood pressure decreases in people with different levels of renin . Under the influence of this component, blood vessels dilate.

When taking the drug, the likelihood of hypokalemia . The mechanism of action of indapamide is similar to thiazide diuretics: urination and excretion of sodium and chloride ions in the urine will increase.

Vascular hyperreactivity decreases under the influence of adrenaline. The amount of lipids in the blood does not change.

Substitutes for imported production

Perindopril

Composition and release form

The Polish analog for blood pressure is available in tablet form, which belongs to the group of ACE inhibitors and diuretics. The tablets contain:

• indapamide;
• perindopril;
• lactose;
• silica;
• magnesium stearate.

Packaging of the drug Perindopril

Pharmacological properties

The blood pressure medication increases renin activity. With prolonged use, total peripheral vascular resistance may decrease.

Perindopril restores myocardial function and reduces the load on the heart.

Other pharmacological properties of Perindopril:

• lowers pressure in the heart muscle;
• normalizes blood circulation;
• removes chlorine and sodium;
• lowers blood pressure levels.

The drug has a pronounced prolonged effect. One tablet lasts for 24 hours. Perindopril can be replaced by Noliprel for hypertension.

Reception scheme

The tablets are taken once a day in the morning.

Contraindications

Perindopril is contraindicated in:

• reporting;
• allergies;
• potassium deficiency;
• liver dysfunction;
• lactose intolerance.

Overdose

In case of an overdose, blood pressure drops sharply, nausea, seizures, and drowsiness appear.

If symptoms of overdose appear, it is necessary to correct hypovolemia.

Indapamide

The diuretic analogue is available in tablet form. It removes water and sodium from the body, normalizing blood pressure. When taking pills regularly, the blood vessels become more elastic and their resistance decreases.

Indapamide is a diuretic

Indapamide can be bought without a prescription. Pharmacies sell different versions of Indapamide tablets from different manufacturers. Only the attending physician can prescribe a drug to correct blood pressure.

Indapamide Teva

The drug is in the form of tablets made in Israel. Tablets are taken 1 time per day. The analogue contains indapamide and perindopril.

Other components:

• lactose;
• polyvinylpyrrolidone;
• bicarbonate of soda.

Perindid

An analogue made in India from . Main components: indapamide and perindopril. Excipients: titanium dioxide, talc, lactose.

Ko-Perineva

Tablets replacing Noliprel, made in Slovenia. Contains: calcium chloride, microcrystalline cellulose, silica.

Perindapam

Blood pressure tablets made in Slovenia. Cheap analogue of Noliprel. The cost starts from 130 rubles. Contains: indapamide, perindopril, microsilica, polyvinylpyrrolidone, hydroxypropyl betadex.

Pharmacokinetics and pharmacodynamics

The pharmacokinetics of perindopril and indapamide when used in combination is the same as when used separately. After oral administration, perindopril is rapidly absorbed. Bioavailability level - 65-70%. About 20% of total absorbed perindopril is later converted to perindoprilat (the active metabolite). The maximum concentration of perindoprilate in plasma is observed after 3-4 hours. Less than 30% binds to blood proteins, depending on the concentration in the blood plasma. The half-life is 25 hours. The substance penetrates the placental barrier. Perindoprilat is excreted from the body through the kidneys. Its half-life is 3-5 hours. There is a slower administration of perindoprilate in older people, as well as in patients with heart failure and renal failure.

Indapamide is completely and relatively quickly absorbed from the gastrointestinal tract. The maximum concentration of the substance in plasma is observed one hour after oral administration.

The substance binds to plasma proteins by 79%. Half-life is 19 hours. The substance is excreted in the form of inactive metabolites by the kidneys (approximately 70%) and intestines (approximately 22%). In people with renal failure, no changes in the pharmacokinetics of the substance are observed.

Domestic analogues

Ko Parnavel

An active analogue of the pharmaceutical drug Noliprel. The blood pressure medication is produced in the form of tablets. The medication has a pronounced diuretic and antihypertensive effect.

Packaging of the drug Co-Parnavel

Perindopril Plus Indapamide

Russian analogue of Noliprel for lowering blood pressure in the form of tablets. Tablets are prescribed instead of Noliprel for hypolactasia. Does not contain lactose.

Contraindications

Contraindications to the use of all types of the drug Noliprel are the following diseases and conditions:

• high sensitivity to the components of the drug or the presence of allergic reactions to its components;
• renal failure , in which creatinine clearance is less than 30 ml/min;
• liver failure , in which there is a tendency to encephalopathy ;
• combination with drugs that prolong the QT interval, as well as antiarrhythmic drugs;
• hypokalemia;
• renal artery stenosis;
• lactase deficiency, glucose-galactose malabsorption syndrome, galactosemia;
• history of angioedema;
• pregnancy , lactation ;
• age up to eighteen years.

Also, you should not take the drug at the same time as potassium supplements or potassium-sparing diuretics if the patient has hyperkalemia.

Due to the lack of sufficient information, it is not recommended to use the tablets for treatment in people who are on hemodialysis , as well as in patients with decompensated heart failure.

It is prescribed with caution to people with systemic connective tissue diseases, those taking antidepressants, and suppression of bone marrow hematopoiesis. angina pectoris are also treated with caution .

Noliprel A, 2.5 mg+0.625 mg, film-coated tablets, 90 pcs.

Noliprel® A

The use of Noliprel® A 2.5 mg + 0.625 mg, containing a low dose of indapamide and perindopril arginine, is not accompanied by a significant reduction in the incidence of side effects, with the exception of hypokalemia, compared with perindopril and indapamide in the lowest doses approved for use (see “Side effects”) actions"). When starting therapy with two antihypertensive drugs that the patient has not previously received, an increased risk of developing idiosyncrasy cannot be excluded. Careful monitoring of the patient can minimize this risk.

Renal dysfunction

Therapy is contraindicated in patients with severe renal failure (creatinine Cl less than 30 ml/min). In some patients with arterial hypertension without previous obvious renal impairment, laboratory signs of functional renal failure may appear during therapy. In this case, treatment should be stopped. In the future, you can resume combination therapy using low doses of drugs, or use drugs in monotherapy.

Such patients require regular monitoring of potassium and creatinine levels in the blood serum - 2 weeks after the start of therapy and every 2 months thereafter. Renal failure occurs more often in patients with severe chronic heart failure or underlying renal impairment, incl. with renal artery stenosis.

Arterial hypotension and water-electrolyte imbalance

Hyponatremia is associated with a risk of sudden development of arterial hypotension (especially in patients with arterial stenosis of a solitary kidney and bilateral renal artery stenosis). Therefore, during dynamic monitoring of patients, attention should be paid to possible symptoms of dehydration and decreased levels of electrolytes in the blood plasma, for example, after diarrhea or vomiting. Such patients require regular monitoring of plasma electrolyte levels.

In case of severe arterial hypotension, intravenous administration of 0.9% sodium chloride solution may be required.

Transient arterial hypotension is not a contraindication for continued therapy. After restoration of blood volume and blood pressure, therapy can be resumed using low doses of drugs, or drugs can be used as monotherapy.

Potassium level

The combined use of perindopril and indapamide does not prevent the development of hypokalemia, especially in patients with diabetes mellitus or renal failure. As in the case of the combined use of an antihypertensive drug and a diuretic, regular monitoring of the level of potassium in the blood plasma is necessary.

Excipients

It should be taken into account that the excipients of the drug include lactose monohydrate. Noliprel® A should not be prescribed to patients with hereditary galactose intolerance, lactase deficiency and glucose-galactose malabsorption.

Lithium preparations

The simultaneous use of a combination of perindopril and indapamide with lithium preparations is not recommended (see “Contraindications”, “Interaction”).

Perindopril

Neutropenia/agranulocytosis

The risk of developing neutropenia while taking ACE inhibitors is dose-dependent and depends on the drug taken and the presence of concomitant diseases. Neutropenia rarely occurs in patients without concomitant diseases, but the risk increases in patients with impaired renal function, especially against the background of systemic connective tissue diseases (including systemic lupus erythematosus, scleroderma). After discontinuation of ACE inhibitors, signs of neutropenia disappear on their own.

To avoid the development of such reactions, it is recommended to strictly follow the recommended dose. When prescribing ACE inhibitors to this group of patients, the benefit/risk factor should be carefully weighed.

Angioedema (Quincke's edema)

When taking ACE inhibitors, incl. and perindopril, in rare cases, the development of angioedema of the face, extremities, lips, tongue, glottis and/or larynx may occur. If symptoms appear, perindopril should be discontinued immediately and the patient should be observed until signs of edema completely disappear. If the swelling affects only the face and lips, it usually resolves on its own, although antihistamines may be used to treat symptoms.

Angioedema, accompanied by swelling of the larynx, can be fatal. Swelling of the tongue, glottis, or larynx can lead to airway obstruction. If such symptoms appear, you should immediately administer subcutaneous epinephrine (adrenaline) at a dilution of 1:1000 (0.3 or 0.5 ml) and/or ensure airway patency.

Patients with a history of angioedema, not associated with taking ACE inhibitors, may have an increased risk of developing it when taking drugs of this group (see “Contraindications”).

In rare cases, angioedema of the intestine develops during therapy with ACE inhibitors.

Anaphylactoid reactions during desensitization

There are isolated reports of the development of long-term, life-threatening anaphylactoid reactions in patients receiving ACE inhibitors during desensitizing therapy with the venom of hymenoptera insects (bees, wasps). ACE inhibitors should be used with caution in patients prone to allergic reactions undergoing desensitization procedures. Prescription of an ACE inhibitor should be avoided in patients receiving immunotherapy with hymenoptera venom. However, an anaphylactoid reaction can be avoided by temporarily discontinuing the ACE inhibitor at least 24 hours before the procedure.

Anaphylactoid reactions during LDL apheresis

In rare cases, life-threatening anaphylactoid reactions may occur in patients receiving ACE inhibitors during LDL apheresis using dextran sulfate or during hemodialysis using high-flow membranes. To prevent an anaphylactoid reaction, ACE inhibitor therapy should be temporarily discontinued at least 24 hours before the apheresis procedure.

Cough

During therapy with an ACE inhibitor, a dry cough may occur. The cough persists for a long time while taking drugs of this group and disappears after their discontinuation. If a patient develops a dry cough, one should be aware of the possible iatrogenic nature of this symptom. If the attending physician believes that ACE inhibitor therapy is necessary for the patient, the drug may be continued.

Children and teenagers

The drug should not be prescribed to children and adolescents under the age of 18 years due to the lack of data on the effectiveness and safety of the use of perindopril as monotherapy or as part of combination therapy in patients in this age group.

Risk of arterial hypotension and/or renal failure (in patients with heart failure, fluid and electrolyte imbalance, etc.)

In some pathological conditions, significant activation of the RAAS system may be observed, especially with severe hypovolemia and a decrease in the level of plasma electrolytes (due to a salt-free diet or long-term use of diuretics), in patients with initially low blood pressure, with bilateral renal artery stenosis or with stenosis of the artery of a single kidney , chronic heart failure or cirrhosis of the liver with edema and ascites.

The use of an ACE inhibitor causes a blockade of this system and therefore may be accompanied by a sharp decrease in blood pressure and/or an increase in plasma creatinine levels, indicating the development of functional renal failure. These phenomena are more often observed when taking the first dose of the drug or during the first two weeks of therapy. Sometimes these conditions develop acutely and during other periods of therapy. In such cases, when resuming therapy, it is recommended to use the drug at a lower dose and then gradually increase the dose.

Elderly patients

Before starting to take the drug, it is necessary to assess the functional activity of the kidneys and the concentration of potassium in the blood plasma. At the beginning of therapy, the dose of the drug is selected taking into account the degree of reduction in blood pressure, especially in the case of dehydration and loss of electrolytes. Such measures help to avoid a sharp decrease in blood pressure.

Atherosclerosis

The risk of arterial hypotension exists in all patients, however, special care should be taken when using the drug in patients with coronary artery disease and cerebrovascular insufficiency. In such patients, treatment should be started with low doses.

Patients with renovascular hypertension

The treatment method for renovascular hypertension is revascularization. However, the use of ACE inhibitors has a beneficial effect in this category of patients, both awaiting surgery and in cases where surgery is not possible.

Treatment with Noliprel® A in patients with diagnosed or suspected bilateral renal artery stenosis or stenosis of the artery of a single kidney should begin with a low dose of the drug in a hospital setting, monitoring renal function and potassium concentration in the blood plasma. Some patients may develop functional renal failure, which disappears when the drug is discontinued.

Other risk groups

In persons with severe heart failure (stage IV) and patients with insulin-dependent diabetes mellitus (risk of spontaneous increase in potassium concentration), treatment should begin with a low dose of the drug and under constant medical supervision.

Patients with arterial hypertension and coronary artery disease should not stop taking beta-blockers: ACE inhibitors should be used together with beta-blockers.

Anemia

Anemia can develop in patients after kidney transplantation or in people on hemodialysis. In this case, the decrease in hemoglobin concentration is greater, the higher its initial value. This effect does not appear to be dose-dependent, but may be related to the mechanism of action of ACE inhibitors.

A slight decrease in hemoglobin concentration occurs during the first 6 months, then it remains stable and is completely restored after discontinuation of the drug. In such patients, treatment can be continued, but hematological tests should be performed regularly.

Surgery/general anesthesia

The use of ACE inhibitors in patients undergoing surgery under general anesthesia can lead to a significant decrease in blood pressure, especially when using general anesthesia agents that have a hypotensive effect.

It is recommended to stop taking long-acting ACE inhibitors, incl. perindopril, the day before surgery. It is necessary to warn the anesthesiologist that the patient is taking ACE inhibitors.

Aortic stenosis/hypertrophic cardiomyopathy

ACE inhibitors should be prescribed with caution to patients with left ventricular outflow tract obstruction.

Liver failure

In rare cases, cholestatic jaundice occurs while taking ACE inhibitors. As this syndrome progresses, liver necrosis may rapidly develop, sometimes with death. The mechanism of development of this syndrome is unclear. If jaundice appears or a significant increase in the activity of liver enzymes while taking ACE inhibitors, you should stop taking the drug and consult a doctor (see “Side effects”).

Indapamide

In the presence of liver dysfunction, taking thiazide and thiazide-like diuretics can lead to the development of hepatic encephalopathy. In this case, you should immediately stop taking the drug.

Water and electrolyte balance

Content of sodium ions in blood plasma.

Before starting treatment, it is necessary to determine the content of sodium ions in the blood plasma. While taking the drug, this indicator should be regularly monitored. All diuretics can cause hyponatremia, which sometimes leads to serious complications. Hyponatremia at the initial stage may not be accompanied by clinical symptoms, so regular laboratory monitoring is necessary. More frequent monitoring of sodium ion levels is indicated for patients with liver cirrhosis and the elderly (see “Side effects” and “Overdose”).

Content of potassium ions in blood plasma.

Therapy with thiazide and thiazide-like diuretics is associated with a risk of hypokalemia. Hypokalemia (less than 3.4 mmol/l) should be avoided in the following categories of high-risk patients: elderly people, debilitated patients or those receiving concomitant drug therapy, patients with liver cirrhosis, peripheral edema or ascites, coronary artery disease, heart failure. Hypokalemia enhances the toxic effect of cardiac glycosides and increases the risk of developing arrhythmias.

The high-risk group also includes patients with an increased QT interval, and it does not matter whether this increase is caused by congenital causes or the effect of drugs.

Hypokalemia, like bradycardia, contributes to the development of severe cardiac arrhythmias, especially arrhythmias, which can be fatal. In all the cases described above, more regular monitoring of the content of potassium ions in the blood plasma is necessary. The first measurement of potassium ion concentration should be carried out within the first week from the start of therapy.

If hypokalemia is detected, appropriate treatment should be prescribed.

Content of calcium ions in blood plasma.

Thiazide and thiazide-like diuretics reduce the excretion of calcium ions by the kidneys, leading to a slight and temporary increase in the concentration of calcium in the blood plasma. Severe hypercalcemia may be a consequence of previously undiagnosed hyperparathyroidism. Before studying the function of the parathyroid glands, you should stop taking diuretics.

Glucose content in blood plasma.

It is necessary to monitor blood glucose levels in patients with diabetes mellitus, especially in the presence of hypokalemia.

Uric acid.

In patients with elevated levels of uric acid in the blood plasma during therapy, the frequency of gout attacks may increase.

Diuretics and kidney function.

Thiazide and thiazide-like diuretics are fully effective only in patients with normal or slightly impaired renal function (plasma creatinine in adults below 25 mg/l or 220 µmol/l).

At the beginning of diuretic treatment in patients, due to hypovolemia and hyponatremia, a temporary decrease in glomerular filtration rate and an increase in the concentration of urea and creatinine in the blood plasma may be observed. This transient functional renal failure is not dangerous for patients with unchanged renal function, but its severity may increase in patients with renal failure.

Photosensitivity

Cases of photosensitivity reactions have been reported while taking thiazide and thiazide-like diuretics. If photosensitivity reactions develop while taking the drug, treatment should be discontinued. If it is necessary to continue diuretic therapy, it is recommended to protect the skin from exposure to sunlight or artificial UV rays.

Athletes

Indapamide may give a positive reaction during doping control.

Effect on the ability to drive a car or use mechanical devices.

The action of the substances included in the drug Noliprel® A does not lead to impairment of psychomotor reactions. However, some people may develop different individual reactions in response to lowering blood pressure, especially at the beginning of therapy or when other antihypertensive drugs are added to therapy. In this case, the ability to drive a car or operate other machinery may be reduced.

Side effects

• In the functions of the cardiovascular system : severe hypotension, orthostatic collapse, in rare cases: arrhythmia , stroke , myocardial infarction .
• In the functions of the genitourinary system : deterioration of kidney function, proteinuria in people with glomerular nephropathy, in rare cases - acute renal failure. There may be a decrease in potency.
• In the functions of the central and peripheral nervous system : severe fatigue, dizziness , headache , asthenia, unstable mood, impaired hearing, vision, decreased appetite, convulsions, and in some cases, stupor.
• In the functions of the respiratory system : cough, difficulty breathing, bronchospasm, nasal discharge.
• In the functions of the gastrointestinal tract : dyspepsia, abdominal pain, pancreatitis , cholestasis, increased transaminase activity, hyperbilirubinemia.
• In the functions of the blood system : against the background of hemodialysis or after a kidney transplant, patients may develop anemia, in rare cases - thrombocytopenia, pancytopenia, agranulocytosis, hemolytic anemia.
• Allergic manifestations : skin itching, rash, swelling, urticaria.
• Patients with liver failure may develop hepatic encephalopathy. People with impaired water-electrolyte balance may experience hyponatremia, hypovolemia, hypokalemia, and dehydration.

Instructions for use of Noliprel (Method and dosage)

It is advisable to take Noliprel tablets in the morning. The medicine is prescribed one tablet per day. The instructions for Noliprel Forte provide for a similar treatment regimen. Noliprel A and Noliprel A Bi Forte are prescribed to patients 1 tablet per day. If patients have creatinine clearance equal to or greater than 30 ml/min, then there is no need to reduce the dose. If clearance equals or exceeds 60 ml per day, then during treatment it is necessary to carefully monitor the level of potassium and creatinine in the blood.

If necessary, after several months of treatment, the doctor may increase the dose by prescribing Noliprel A Forte or another type of this drug instead of Noliprel.

Noliprel A Bi-forte is the main substitute for Noliprel

Composition and release form

The main analogue of the drug Noliprel is Noliprel A Bi-forte. These are tablets with similar pharmacological effects, but each tablet contains more active ingredients (10 mg of perindopril and 2.5 mg of indapamide).

Pharmacological properties

The analogue is prescribed for high blood pressure. It belongs to the angiotensin-predominant enzyme inhibitors with a pronounced diuretic effect. Contains indapamide and perindopril.

The complex effect has a pronounced hypotensive effect. The drug is prescribed for primary hypertension.

Noliprel A Bi-forte is an enhanced formula of the original drug

Reception scheme

The drug is taken twice a day, morning and evening, 1 tablet. For minor liver dysfunction, no dose adjustment is required.

The analogue is contraindicated in severe liver failure.

Contraindications

Blood pressure medication Noliprel A Bi-forte should not be taken if:

• individual intolerance to components;
• pregnancy;
• hemodialysis.

Side effects

When taking blood pressure tablets Noliprel A Bi-forte, undesirable reactions from the body may develop:

• tinnitus;
• anemia;
• a strong decrease in blood pressure;
• uncontrollable headache attacks;
• insomnia;
• allergic reactions;
• runny nose.

Overdose

If the prescribed dosage is exceeded, the patient may experience the following symptoms:

• gagging;
• drowsiness;
• decrease in pressure indicators to critical values;
• water-electrolyte imbalance.

In case of overdose, it is necessary to rinse the stomach, drink an adsorbent and consult a doctor.

Drug interactions

Blood pressure tablets Noliprel A Bi-forte should not be taken simultaneously with lithium-containing medications. This may lead to a risk of overdose and lithium poisoning. When combined with these drugs, it is necessary to monitor blood counts and lithium concentrations.

You cannot take Noliprel A Bi-forte tablets and the muscle relaxant Baclofen, as this will increase the hypotensive effect of Noliprel.

Noliprel A Bi-forte tablets are not prescribed simultaneously with tricyclics, as they enhance the pharmacological properties of Noliprel.

When taking corticosteroids, the antihypertensive effect of Noliprel A Bi-forte is reduced.

When taking the drug Noliprel A Bi-forte simultaneously with cytostatic agents or Allopurinol, the risk of a decrease in the level of leukocytes in the blood increases.

During the course of taking blood pressure pills, you should not drink alcohol.

Overdose

In case of an overdose of the drug, there is a severe decrease in blood pressure, nausea, vomiting, dizziness , mood instability, symptoms of renal failure, and electrolyte imbalance. In this case, you need to immediately bring the water-electrolyte balance back to normal, rinse the stomach, and take enterosorbents. Noliprel metabolites can be removed using dialysis. If necessary, intravenous saline is administered.

Interaction

Noliprel should not be taken at the same time as lithium medications. If it is impossible to discontinue one of the drugs, the lithium level in the blood should be closely monitored.

With simultaneous treatment with potassium-sparing diuretics or drugs with potassium, the concentration of potassium in the blood may increase. This combination is recommended only for hypokalemia.

When indapamide with vincamine, bepridil, sultopride, halofantrine, as well as with simultaneous intravenous administration of erythromycin , arrhythmia and bradycardia may occur.

Sometimes, with simultaneous treatment with Insulin and Noliprel, hypoglycemia may develop.

When taking non-steroidal anti-inflammatory drugs, the antihypertensive properties of Noliprel are inhibited. If you are dehydrated, this combination of medications can cause kidney problems or kidney failure.

When treated with Noliprel and antipsychotics or tricyclic antidepressants, orthostatic hypotension may develop.

Due to the retention of water and electrolytes in the body, with simultaneous treatment with Noliprel and mineralocorticoids, glucocorticosteroids, stimulant laxatives, tetracosactide, amphotericin B, the hypotensive effect is reduced and the likelihood of hypokalemia increases.

Due to the possibility of developing hypokalemia, the risk of toxic effects of cardiac glycosides increases.

When combined with Metformin, acidosis may develop .

Before using iodine-containing X-ray contrast agents with Noliprel, the body must be adequately hydrated.

The simultaneous use of calcium salts can provoke hypercalcemia.

Concomitant treatment with cyclosporine may increase blood creatinine levels.

What should you not combine ACE inhibitors with?

Angiotensin-converting enzyme inhibitors are not compatible with certain other drugs:

• lithium-containing drugs: increase the lithium content in the blood;
• muscle relaxant Baclofen: increases the hypotonic effect;
• non-steroidal anti-inflammatory drugs: reduce the effectiveness of ACE inhibitors.

Separately, doctors distinguish combinations of drugs:

• psychotropic and neuroleptic;
• corticosteroids and tetracosactides.

Taking these medications may cause the development of adverse reactions. If renal function is impaired, the drugs cannot be prescribed together. If signs of renal impairment appear during the course of treatment, it is necessary to discontinue therapy. During treatment, it is necessary to monitor the creatinine level in the blood.

special instructions

People who have been prescribed treatment with Noliprel need adequate dehydration of the body to prevent a sharp decrease in blood pressure.

People with heart failure may be treated with beta blockers at the same time.

When treated with Noliprel, a positive reaction is observed during a doping test.

In the first weeks of treatment, it is important to drive vehicles or operate precision machinery carefully when treating with Noliprel.

If during treatment there is a significant decrease in pressure, it may be necessary to administer 0.9% sodium chloride intravenously.

Treatment of patients with cerebral circulatory insufficiency or coronary heart disease should begin with small doses of Noliprel.

In people who have very high levels of uric acid in the blood, when treated with varieties of the drug Noliprel, the risk of developing gout .

Noliprel's analogs

Level 4 ATX code matches:
Akkuzid

Enap-N

Iruzid

Co-Diroton

Enalozide

Enap NL

Enapril-N

Capozide

Tritace Plus

Enzix

Liprazid

Co-Renitec

Hartil N

Hartil D

Ko-Perineva

Kaptopres

Analogs of Noliprel, as well as the drugs Noliprel A Bi Forte, Noliprel A Forte, are other drugs that are used to lower blood pressure and contain similar active ingredients, that is, perindopril and indapamide. Such drugs are Co-prenesa , Prestarium , etc. The price of analogues may be lower than the cost of Noliprel and its varieties.

Noliprel A forte is an identical drug

Composition and release form

The analogue is produced in tablet form with a thin film. The main active ingredients are indapamide and perindopril in double dosage - 1.25 mg and 5 mg, respectively. The tablets lower blood pressure and remove water from the body.

Noliprel A forte is a complete analogue of the original drug with prolonged action

Pharmacological properties

Noliprel A forte has a prolonged effect. To achieve a pharmacological effect, 1 tablet per day is sufficient. A pronounced hypotensive effect is achieved after a month of therapy.

Reception scheme

The tablets are taken before meals. 1 tablet per day is enough. The drug is taken as a single drug or in combination with other medications.

Contraindications

Noliprel A forte tablets should not be taken if:

• potassium deficiency;
• renal failure.

The drug is prescribed with caution for connective tissue diseases.

During pregnancy and lactation

For pregnant women and mothers while breastfeeding , the use of Noliprel is contraindicated. Systematic treatment with these drugs can lead to the development of abnormalities and diseases in the fetus, as well as lead to fetal death. If a woman finds out she is pregnant during treatment, there is no need to terminate the pregnancy, but the patient should be aware of the possible consequences. If blood pressure increases, other antihypertensive therapy is prescribed. If a woman took this drug in the second and third trimesters, an ultrasound of the fetus should be performed to evaluate the condition of its skull and kidney function.

Newborns whose mothers took the drug may suffer from manifestations of arterial hypotension, so they need to be constantly monitored by specialists.

When feeding with breast milk, the drug is contraindicated, so lactation should be stopped during therapy or another drug should be selected.

Combination drugs

Combination-type drugs are convenient to take for high blood pressure, since 2 tablets replace 1. Combined drugs are prescribed after examination and determination of the absence of contraindications. If taking a combination drug is not possible, a single drug is prescribed.

Original analogues include Prestarium A (perindopril) plus Arifon (indapamide).

Arifon can be replaced with Ravel and Indap. Arifon has a potent analogue, Arifon Retard, with a higher content of indapamide. Its analogues are Perineva and Parnavel.

Original drugs can be replaced with generic Noliprel (see above).

Reviews of Noliprel

Reviews on forums about Noliprel, as well as about the drugs Noliprel A, Noliprel A Forte, Noliprel A Bi Forte, indicate that this drug effectively lowers blood pressure. The medicine maintains normal blood pressure, reducing the likelihood of strokes and myocardial infarction.

Reviews of Noliprel Forte also often contain information that this medicine and its other varieties allow you to get a positive result in cases where other drugs are ineffective. Sometimes patients note the development of some side effects, in particular, dry cough, headache, but they are not very intense.

Doctors also note the positive effect of the drug, but they always note that the drug must be taken strictly according to the instructions and taking into account the recommendations of a specialist. In particular, the drug should be taken regularly, and not only during periods of intense surges in blood pressure.

Noliprel price, where to buy

The price of Noliprel is on average 500 rubles per pack of 30 pcs. The price in Moscow for Noliprel A is from 500 to 550 rubles. The price for Noliprel Forte is from 550 rubles per package. Noliprel A Forte 5 mg can be purchased at a price of 650 rubles. The cost of Noliprel A Bi Forte is from 700 rubles. per pack 30 pcs.

• Online pharmacies in RussiaRussia
• Online pharmacies in UkraineUkraine
• Online pharmacies in KazakhstanKazakhstan

ZdravCity

• Noliprel A Bi-Forte tablets p.p.o.
  10mg+2.5mg 30 pcs. Servier Rus LLC 783 rub. order
• Noliprel A Forte tablets p.p.o. 5mg+1.25mg 30 pcs. Servier Rus LLC

  RUR 741 order

• Noliprel A tablets p.p.o. 2.5 mg + 0.625 mg 30 pcs. Serdix LLC/SERVIER RUS LLC

  RUR 638 order

Pharmacy Dialogue

• Noliprel A Bi-forte tablets 10mg+2.5mg No. 30Servier

  RUR 784 order

• Noliprel A tablets 2.5 mg + 0.625 mg No. 30Servier

  630 rub. order

• Noliprel A forte tablets po 5mg+1.25mg No. 30Servier

  RUB 844 order

show more

Pharmacy24

• Noliprel Bi Forte 10 mg No. 30 tablets Laboratories Serv'e Industry/Serve'e (Ireland) Industry Ltd., France/Ireland
  207 UAH.order
• Noliprel Arginine Forte 5 mg N30 tablets Lab.Serve Industries, France/Serve Industries Ltd., Ireland

  176 UAH order

• Noliprel Arginine 2.5 mg No. 30 tablets Laboratories Serv'e Industry/Serve'e (Ireland) Industries Ltd., France/Ireland

  141 UAH order

PaniPharmacy

• Noliprel arginine tablets Noliprel Arginine film-coated tablets 2.5 mg No. 30 France, Servier Industrie

  164 UAH order

• Noliprel arginine tablets Noliprel Arginine tablets No. 30 France, Servier Industrie

  155 UAH order

• Noliprel Arginine Forte tablets Noliprel Arginine Forte tablets No. 30 France, Servier Industrie

  200 UAH order

• Noliprel bi-Forte tablets Noliprel BI-Forte tablets No. 30 France, Servier

  229 UAH order

show more